Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.

@article{Kauert2007PharmacokineticPO,
  title={Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.},
  author={Gerold F. Kauert and Johannes G Ramaekers and Erhard Schneider and Manfred R. Moeller and Stefan W. Toennes},
  journal={Journal of analytical toxicology},
  year={2007},
  volume={31 5},
  pages={
          288-93
        }
}
In a study on the effects of smoked cannabis (18.2 +/- 2.8 mg as low and 36.5 +/- 5.6 mg as high dose) paired blood and oral fluid samples were collected from 10 study participants up to 6 h after smoking and analyzed for the cannabinoids Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (THC-OH) and 11-nor-9-carboxy-THC (THCA) using gas chromatography-mass spectrometry. Highest concentrations in serum were 47.8 +/- 35.0 and 79.1 +/- 42.5 microg/L at the end of smoking (low and high dose… 

Figures and Tables from this paper

Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid.
TLDR
In this study, 17 heavy cannabis users consumed alcohol to achieve steady blood alcohol concentrations of 0 to 0.7 g/L and smoked cannabis 3 h afterward and on-site tests were performed, indicating sufficient sensitivity for recent cannabis use.
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
TLDR
Despite multiple oral THC administrations each day and increasing plasma THC concentrations, OF THC concentrations generally decreased over time, reflecting primarily previously self-administered smoked cannabis.
Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
TLDR
The detection of JWH-018 in oral fluid requires high analytical sensitivity even 1 hour after inhalation, and high variability of the oral fluid/serum ratio precludes extrapolation of oral fluid concentrations to blood.
Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration
TLDR
Measurement of THCCOOH may improve the detection and interpretation of OF cannabinoid tests and minimize the possibility of OF contamination from passive inhalation of cannabis smoke.
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration
TLDR
Evaluating OF to plasma (OF/P) cannabinoid ratios provides important pharmacokinetic data on the disposition of drug and factors influencing partition between matrices for making inferences of impairment or other clinical outcomes from OF concentrations.
Cannabinoid disposition in oral fluid after controlled smoked cannabis.
TLDR
By quantifying multiple cannabinoids and evaluating different analytical cutoffs after controlled cannabis smoking, the windows of drug detection, found suggested markers of recent smoking, and minimized the potential for passive contamination are determined.
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users
TLDR
Concentrations and pharmacokinetics of 11-hydroxy-THC and 11-nor-9-carboxy-thC (THCA) were not significantly influenced by ethanol, however, THCA concentrations appeared lower in both ethanol conditions, which might also be attributable to changes in distribution.
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.
Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint.
TLDR
From the results, it must be cautioned that cannabinoid blood concentrations from heavy users in a late elimination phase may be difficult to distinguish from concentrations measured in occasional users after acute cannabis use.
...
...

References

SHOWING 1-10 OF 26 REFERENCES
Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.
TLDR
Physiological, psychological, and pharmacokinetic data revealed few differences between frequent and infrequent marijuana users.
Tolerance and disposition of tetrahydrocannabinol in man.
  • C. A. Hunt, R. Jones
  • Medicine, Biology
    The Journal of pharmacology and experimental therapeutics
  • 1980
TLDR
It is concluded that such pharmacokinetic and metabolic changes cannot account for the development of tolerance to the cardiovascular, psychological and skin hypothermic effects of THC.
Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
TLDR
It is concluded that a positive oral fluid test provides credible evidence of active cannabis use and the similarity in oral fluid and plasma THC concentrations following the dissipation of the initial "contamination" indicates the likelihood of a physiological link between these specimens.
Plasma delta‐9‐tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking
TLDR
After oral THC, the onset of clinical effects was much slower and lasted longer, but effects occurred at much lower plasma concentrations than after the other two methods of administration, suggesting that brain concentrations were increasing as plasma concentrations decreased.
Assay of Delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device.
TLDR
It can be concluded that the OraSure OSCD is useful to collect oral fluid for reliable quantitative THC assay applying a modified elution procedure and gravimetric determination of the amount of oral fluid.
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
TLDR
This study provides the first complete pharmacokinetic profile of the absorption of THC and appearance of metabolites during marijuana smoking, which has implications for understanding the mechanisms underlying the performance-impairing effects of marijuana, as well as for aiding forensic interpretation of cannabinoid blood levels.
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.
TLDR
The results indicate that heavy cannabis users smoke more efficiently than casual smokers, and both light and heavy users showed more clinical effect following IV administration than after smoking.
Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
TLDR
It was concluded that oral fluid testing for THC offers specific advantages over other means of marijuana testing when used in safety-sensitive testing programs.
Pharmacokinetics and Pharmacodynamics of Cannabinoids
TLDR
Properties of cannabis that might be of therapeutic use include analgesia, muscle relaxation, immunosuppression, sedation, improvement of mood, stimulation of appetite, antiemesis, lowering of intraocular pressure, bronchodilation, neuroprotection and induction of apoptosis in cancer cells.
...
...